MBRX vs PNW · $8.2M cap vs P/E 19, rev $2.61B
Moleculin Biotech Inc (MBRX) versus Pinnacle West Capital Corp (PNW) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
MBRX currently screens at market cap $8.2M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Not investment advice. Open the MBRX and PNW stock pages for the full models.
Not investment advice.